Accelerating Drug Development in Hormone-Naïve Prostate Cancer and Changing the Paradigm from Palliation to Cure: The Metacure Phase 2 Randomized Clinical Trial
Year: 2024
Type: preprint
Study design: Clinical Trial
Source: SSRN Electronic Journal
DOI: 10.2139/ssrn.4933442
Authors: Deaglan McHugh, Min Yuen Teo, Sean McBride, Anuradha Gopalan, Andrea Arfe, Christopher Gaffney, Hannah Benoliel, Alvin C. Goh, Kevin DeRudder, Catherine Ryan, Russell Z. Szmulewitz, Alicia Morgans, Glenn Bubley, Shilpa Gupta, Eric A. Klein, Paul L. Nguyen, Adam S. Kibel, Andrew A. Wagner, Irving D. Kaplan, Scott Eggener, David Einstein, Andres M. Acosta, Rahul Tendulkar, David VanderWeele, William Catalona, Sean Sachdev, Stan Liauw, James Eastham, Mary-Ellen Taplin, Howard I. Scher
Institutions: Memorial Sloan Kettering Cancer Center, Harvard University, Dana-Farber Cancer Institute, University of Chicago, Cleveland Clinic, Brigham and Women's Hospital, Riley Hospital for Children, Indiana University School of Medicine, Indiana University – Purdue University Indianapolis, Northwestern University, Robert H. Lurie Comprehensive Cancer Center of Northwestern University
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W4401815857